Eisler Capital (Uk) Ltd. Bristol Myers Squibb CO Transaction History
Eisler Capital (Uk) Ltd.
- $21.6 Billion
- Q3 2024
A detailed history of Eisler Capital (Uk) Ltd. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Eisler Capital (Uk) Ltd. holds 11,317 shares of BMY stock, worth $652,425. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,317
Previous 34,919
67.59%
Holding current value
$652,425
Previous $1.45 Million
59.66%
% of portfolio
0.0%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding BMY
# of Institutions
2,537Shares Held
1.47BCall Options Held
31.6MPut Options Held
35M-
Vanguard Group Inc Valley Forge, PA189MShares$10.9 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.15 Billion0.15% of portfolio
-
State Street Corp Boston, MA92.9MShares$5.36 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY77.9MShares$4.49 Billion0.33% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA61MShares$3.52 Billion0.61% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $123B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...